ALLMedicine™ Urinary Tract Infections Center

Sep 25th, 2020 - The inexorable rise of antimicrobial resistance reinforces the need for alternative approaches to both treat and prevent urinary tract infections (UTIs). A potential approach is administration of D-mannose, an inert monosaccharide that is metaboli...

Sep 23rd, 2020 - A single carbapenem-resistant and hypervirulent Klebsiella pneumoniae strain attracts a major public concern. The aim of the present study was to better understand the antimicrobial resistance and the genetic characteristics of Klebsiella pneumoni...

Sep 22nd, 2020 - The gut microbiota influences many aspects of human health. We investigated the magnitude and duration of changes in gut microbiota in response to antibiotics commonly prescribed in UK primary care. We searched MEDLINE, EMBASE and AMED, all years ...

Sep 22nd, 2020 - Rapid detection of extended-spectrum β-lactamases is essential. In this study, we evaluated the potential impact of β-lacta test on both the times to appropriate antibiotic therapy and to the implementation of patient isolation measures. We includ...

Sep 19th, 2020 - Biofilms of Pseudomonas aeruginosa can cause complicated urinary tract infections especially in people with indwelling catheters which may result in pyelonephritis. Microorganisms in biofilm demonstrate high resistance to both antibiotics and host...

Jul 29th, 2019 - Background: Prior studies evaluating risk for severe urinary tract infections (UTIs) with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have reported conflicting findings. Objective: To assess whether patients initiating use of SGLT-2 inhibi...

Jul 16th, 2019 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved RECARBRIO™ (imipenem, cilastatin, and relebactam) for injection, 1.25 grams, a new combination antib...

Jun 30th, 2019 - Doxycycline is an antibiotic used to treat bacterial infections like urinary tract infections, acne and chlamydia. Includes side effects, interactions and indications.

Apr 30th, 2019 - Over the past few decades, our ability to diagnose, treat, and manage recurrent urinary tract infection (rUTI) long-term has evolved due to additional insights into the pathophysiology of rUTI, a new appreciation for the adverse effects of repetit...

Dec 11th, 2018 - Cephalexin treats infections caused by bacteria, including ear infections, skin infections, and urinary tract infections. Includes cephalexin side effects interactions and indications.

Mar 30th, 2021 - Fluconazole tablets USP are indicated for the treatment of: 1.Vaginal candidiasis (vaginal yeast infections due to Candida). 2.Oropharyngeal and esophageal candidiasis. In open noncomparative studies of relatively small numbers of patients, flucon...

Sep 25th, 2020 - The inexorable rise of antimicrobial resistance reinforces the need for alternative approaches to both treat and prevent urinary tract infections (UTIs). A potential approach is administration of D-mannose, an inert monosaccharide that is metaboli...

Sep 23rd, 2020 - A single carbapenem-resistant and hypervirulent Klebsiella pneumoniae strain attracts a major public concern. The aim of the present study was to better understand the antimicrobial resistance and the genetic characteristics of Klebsiella pneumoni...

Sep 23rd, 2020 - Fluconazole tablets are indicated for the treatment of: Vaginal candidiasis (vaginal yeast infections due to Candida). Oropharyngeal and esophageal candidiasis. In open noncomparative studies of relatively small numbers of patients, fluconazole ta...

Sep 22nd, 2020 - The gut microbiota influences many aspects of human health. We investigated the magnitude and duration of changes in gut microbiota in response to antibiotics commonly prescribed in UK primary care. We searched MEDLINE, EMBASE and AMED, all years ...

Jun 19th, 2020 - (Reuters) - The U.S. Food and Drug Administration declined to approve Nabriva Therapeutics Plc’s antibiotic for complicated urinary tract infections, citing still-unresolved manufacturing issues, the biopharmaceutical company said on Friday. Nabri...

Mar 3rd, 2020 - A multifaceted intervention significantly changed clinicians’ use of antibiotics to treat urinary tract infections (UTIs) in children, according to data from more than 2,000 cases observed between January 2014 and September 2018. “Changing clinici.

Nov 15th, 2019 - The Food and Drug Administration announced that it has approved cefiderocol (Fetroja), an IV antibacterial drug to treat complicated urinary tract infections (cUTIs), including kidney infections, caused by multidrug-resistant gram-negative microor.

Oct 28th, 2019 - FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo (Reuters) - GlaxoSmithKline Plc said on Monday it has begun a late-stage study testing its experimental ant...

Oct 16th, 2019 - SILVER SPRING, Md. -- An FDA advisory panel voted 14-2 to recommend approval for cefiderocol, a novel antibiotic for complicated urinary tract infections (cUTI), including pyelonephritis, in patients with limited or no other treatment options. Whi...